Equities

Certara Inc

Certara Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)10.93
  • Today's Change0.10 / 0.92%
  • Shares traded1.19m
  • 1 Year change-21.82%
  • Beta1.5084
Data delayed at least 15 minutes, as of Sep 18 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development in the global biopharmaceutical industry. It is focused on producing medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its customers include life sciences companies of all sizes along with contract research organizations, academic institutions, and global regulators. Its software and service are used by approximately 2,400 biopharmaceutical companies and academic institutions across 66 countries, including 38 of the top 40 biopharmaceutical companies. It has operations in the United States, Australia, Canada, China, France, Germany, India, Italy, Japan, Luxembourg, Netherlands, Philippines, Poland, Portugal, Spain, Switzerland, Egypt, and the United Kingdom.

  • Revenue in USD (TTM)363.55m
  • Net income in USD-78.68m
  • Incorporated2017
  • Employees1.34k
  • Location
    Certara Inc4 Radnor Corporate Center, Suite 350RADNOR 19087United StatesUSA
  • Phone+1 (415) 237-8272
  • Fax+1 (302) 636-5454
  • Websitehttps://www.certara.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
CERT:NSQ since
announced
Transaction
value
Formedix LtdDeal completed10 Oct 202310 Oct 2023Deal completed-23.08%39.00k
Data delayed at least 15 minutes, as of Sep 18 2024 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Schrodinger Inc200.63m-201.47m1.43bn867.00--3.01--7.12-2.79-2.792.786.510.2623--5.31231,403.70-26.34-9.33-30.45-10.8765.5057.58-100.42-35.93----0.00--19.7326.59127.29--20.58--
Matterport Inc162.28m-266.41m1.47bn438.00--3.55--9.05-0.8525-0.85250.52291.290.27818.139.04370,490.90-45.65---54.84--47.50---164.17--2.67--0.00--15.88---78.80------
Getty Images Holdings Inc906.66m38.01m1.47bn1.70k43.322.2413.921.620.08270.08272.171.590.3601--7.46533,326.501.51--1.81--72.76--4.18----1.450.6577---1.05--113.12------
Rumble Inc78.58m-128.37m1.57bn158.00--11.20--20.00-0.6344-0.63440.38820.49540.2605--9.27497,322.90-42.56---48.98---86.84---163.37------0.00--105.57---920.87------
Sprout Social Inc375.30m-73.56m1.64bn1.38k--10.76--4.36-1.31-1.316.672.671.05--7.44271,363.70-20.49-18.32-39.41-28.7677.0975.67-19.60-22.14----0.2082--31.4433.46-32.22---0.23--
Pagerduty Inc446.94m-83.06m1.64bn1.18k--9.97--3.68-0.8942-0.89424.811.770.5173--6.75378,125.20-8.15-12.68-12.36-17.7582.2282.78-15.76-29.62----0.7131--16.1629.6036.34--12.88--
Liveramp Holdings Inc681.55m4.19m1.72bn1.40k438.271.81105.942.520.05890.085710.2014.230.5751--3.59486,823.600.3534-5.630.4171-6.4872.7769.570.6145-13.93----0.00--10.5718.22108.13---13.21--
Certara Inc363.55m-78.68m1.74bn1.34k--1.67--4.79-0.4935-0.49352.286.490.2337--4.19271,713.80-5.06-1.68-5.46-1.7959.0160.39-21.64-7.86---1.080.2214--5.5716.70-475.79--5.93--
Genius Sports Ltd444.07m-97.40m1.82bn2.30k--3.02--4.09-0.3993-0.39931.872.620.5982801.944.71193,072.20-13.12---16.35--17.11---21.93--1.54--0.00006--21.10--52.91------
Ibotta Inc355.21m2.39m1.85bn815.00--5.14216.275.21-0.1215-0.121512.2111.75------435,845.40--------87.08--0.6728------0.00--51.89--169.48------
EverCommerce Inc691.69m-43.65m1.95bn2.10k--2.4936.362.82-0.2326-0.23263.694.250.4594--10.20329,374.80-2.90---3.14--66.02---6.31----1.380.4034--8.80--23.73------
Sprinklr Inc773.70m50.59m1.98bn3.87k44.404.2229.092.560.17590.17592.731.850.7525--4.14199,973.604.92--8.62--74.26--6.54------0.00--18.47--192.22------
Sapiens International Corporation NV532.61m68.82m2.00bn5.00k29.164.3522.163.751.231.239.528.250.8066--5.56106,522.6010.477.2613.339.2843.1041.3712.9810.36----0.079247.288.3912.1818.7335.275.5520.59
JOYY Inc (ADR)2.27bn266.05m2.03bn7.45k8.930.3924--0.89553.983.9834.0490.970.2744--19.13304,281.902.321.673.672.2935.5132.488.466.59----0.0145211.76-5.9678.43190.7674.026.67--
Data as of Sep 18 2024. Currency figures normalised to Certara Inc's reporting currency: US Dollar USD

Institutional shareholders

41.09%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Jun 202412.46m7.74%
The Vanguard Group, Inc.as of 30 Jun 202412.34m7.67%
Baillie Gifford & Co.as of 30 Jun 20248.36m5.19%
Wasatch Advisors LPas of 30 Jun 20247.36m4.58%
Geneva Capital Management LLCas of 30 Jun 20245.47m3.40%
William Blair Investment Management LLCas of 30 Jun 20245.23m3.25%
ClearBridge Investments LLCas of 30 Jun 20244.09m2.54%
JPMorgan Investment Management, Inc.as of 30 Jun 20243.76m2.34%
SSgA Funds Management, Inc.as of 30 Jun 20243.56m2.21%
ArrowMark Colorado Holdings LLCas of 30 Jun 20243.48m2.17%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.